NCBI PubMed Central
open access
Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Early Serum Infliximab Levels in Severe Ulcerative Colitis.#1095781
- JAK Inhibition in Ulcerative Colitis#1173563
- Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.#1096934
- Image 1_Predictive model for ulcerative colitis therapeutic response using clinical indicators and peripheral blood T-cell subsets.tiff#624483
- Cytokines and Genes in Therapeutic Response in Crohn's Disease#1103926
Record · ID 625950
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive